Mov Disord Vol 34, Suppl 2 Archives - Page 141 of 217 - MDS Abstracts

2019 International Congress
Internal pallidum stimulation reduces mobile generalized dystonia in Wilson’s disease
S. Paschen, A. Helmers, J. Volkmann, G. Deuschl, D. Berg, KE. Zeuner (Kiel, Germany)
Objective: Globus Pallidus internus (GPi) deep brain stimulation (DBS) is established in treatment of dystonia. We evaluated safety and efficacy of bilateral GPi stimulation in…
2019 International Congress
Increased level of a lysosomal phospholipid, BMP, in urine of LRRK2 G2019S mutation carriers with or without Parkinson’s disease: implications for therapeutic development
R. Alcalay, F. Hsieh, S. Padmanabhan, M. Baptista, C. Kehow, S. Narayan, A. Boehme, K. Merchant (Cambridge, MA, USA)
Objective: To study alterations in urinary phospholipids as biomarkers of LRRK2 mutations and Parkinson’s disease (PD) status. Background: LRRK2 mutations are a common cause of…
2019 International Congress
The influence of gender, associated neurological disorder and motive for polysomnography (PSG) in the manifestations of REM sleep behaviour disorder (RBD)
P. Bugalho, M. Salavisa (Lisbon, Portugal)
Objective: To access the interrelation and relative influence of gender, associated neurological disorder and context of referral to PSG on the manifestations of (RBD). Background:…
2019 International Congress
Restless leg syndrome in Neuro-Behcet’s and Behcet’s disease
M. Kuzu Kumcu, S. Erdoğan, M. Sorgun, C. Yücesan (Ankara, Turkey)
Objective: The goal of this study is the comparison of the restless leg syndrome frequency in the BD and NBD patients and also to investigate…
2019 International Congress
An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia
R. Ayyagari, D. Goldschmidt, F. Mu, S. Caroff, B. Carroll (Boston, MA, USA)
Objective: Evaluate the impact of orofacial tardive dyskinesia (TD) symptoms on the professional and social lives of patients with TD. Background: TD, a movement disorder…
2019 International Congress
The influence of relationship quality on health-related quality of life when coping with Parkinson’s disease: a mediation analysis
M. Karlstedt, SM. Fereshtehnejad, D. Aarsland, J. Lökk (Huddinge, Sweden)
Objective: To explore motor and non-motor symptoms (NMS) influence on relationship quality (mutuality) and health-related quality of life (HRQoL) when one in the dyad is…
2019 International Congress
Understanding the Needs and Concerns of Newly Diagnosed People with Parkinson’s Disease
V. Todaro, M. Feeney, A. Diaz, S. Rosenfeld, J. Gannon (New York, NY, USA)
Objective: To identify the concerns of those newly diagnosed with Parkinson’s (up to three years since diagnosis) through an online survey and utilize findings to inform…
2019 International Congress
Reliability and Validity of Modified Four Square Step Test (mFSST) Performance in Individuals with Parkinson’s Disease.
A. Boddy, K. Mitchell, W. Brewer, J. Ellison, L. Perry, C. Andrea (St. Augustine, FL, USA)
Objective: Determine the reliability and validity of the modified Four Square Step Test in individuals with Parkinson’s disease. Background: Parkinson’s disease (PD) is a complex…
2019 International Congress
TELE PARK: Evaluation of the appropriation of a digitally guided self-rehabilitation device for patients with Parkinson’s disease and their professional entourage on a health territory in Brittany, France.
E. Leblong, AL. Roy, B. Fraudet, A. Riou, A. Durufle, JF. Aubry, B. Nicolas, P. Gallien (Rennes, France)
Objective: The main objective of this study is to evaluate the appropriation of BYM by patients and their liberal physiotherapists in a health area in…
2019 International Congress
The statement about the effectiveness of non-medication methods in the complex treatment of spasticity of different genesis
O.. Tondiy (Kharkiv, Ukraine)
Objective: Considering polypragmasy and many side effects of drugs, the need for non-drug components of the treatment complex is always relevant. Background: The effect of…